We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pancreatic Cancer Surgery Option Overlooked

By HospiMedica staff writers
Posted on 26 Jun 2007
A new study has found that nearly 40% of patients with early pancreatic cancer who could be treated with surgery do not get the operation, grimly reducing their chances of survival.

Researchers at Northwestern University Medical School (Chicago, IL, USA) conducted an analysis of a U.S. More...
national cancer database maintained by the American College of Surgeons. The researchers found that 3,644 patients out of 9,559 with early-stage disease, or about 38%, were not offered surgery. Blacks, patients older than 65, and those with lower annual incomes and education were the least likely to be offered surgery.

The study also found that about 30% of patients with early-stage disease who undergo surgery could be expected to survive at least five years, compared with less than 5% of early-stage patients who do not get the operation. The study was published ahead of print during June 2007, in the online version of Annals of Surgery.

"The complicated operation is tricky but safer than previously thought and can extend life, although chances of surviving five years are still not great,” said study co-author Dr. Mark Talamonti, a cancer surgeon at Northwestern Memorial Hospital (Chicago, IL, USA) and chief of surgical oncology at Northwestern University. "It is still a formidable disease, but if you're caught with early-stage disease, at least there is reasonable hope.”

Nearly all patients who survive pancreatic cancer surgery undergo an operation called the Whipple procedure. This seven- to eight-hour surgery includes removing most or all of the pancreas, part of the intestine, the entire gallbladder, and part of a bile duct.


Related Links:
Northwestern University Medical School

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.